Want to see COSM full AI Analyst Report?
COSM Stock Chart & Stats
$0.52
-$0.04(-5.45%)
At close: 4:00 PM EST
$0.52
-$0.04(-5.45%)
Day’s Range― - ―
52-Week Range$0.16 - $1.32
Previous CloseN/A
Volume59.12K
Average Volume (3M)1.18M
Market Cap
$18.17M
Enterprise Value$31.91M
Total Cash (Recent Filing)$548.93K
Total Debt (Recent Filing)$17.42M
Price to Earnings (P/E)―
Beta2.20
Next Earnings
Aug 24, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding62,078,396
10 Day Avg. Volume1,246,475
30 Day Avg. Volume1,183,471
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.82
Price to Sales (P/S)0.23
P/FCF Ratio-1.77
Enterprise Value/Market Cap1.76
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit4.42
Enterprise Value/Ebitda-1.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.08
Revenue Forecast (FY)$103.20M
Bulls Say, Bears Say
Bulls Say
Revenue Growth MomentumSustained near-30% reported revenue growth and TTM sales of ~$69.5M indicate expanding commercial traction in core channels. Durable top-line expansion provides a larger base to leverage fixed costs and supports the possibility of margin recovery if cost structure is managed and scale is maintained.
Improved Leverage And Positive EquityMaterial reduction in leverage versus 2025 and positive equity (~$19.8M) improve financial flexibility. Lower debt-to-equity (~0.48) reduces near-term refinancing risk and interest burden, giving the company more durable capacity to fund operations or strategic initiatives without immediate reliance on dilutive capital.
B2B Pharmaceutical Distribution ModelA business-to-business pharmaceutical and medical-device distribution model benefits from recurring, contract-driven demand and established customer relationships. Structural healthcare demand and supply-chain positioning create a durable revenue base less exposed to retail volatility and support long-term cash flow stability if margins improve.
Bears Say
Thin Gross And Negative Operating MarginsVery thin gross margins limit the company's ability to absorb SG&A, distribution and R&D costs. Deeply negative operating and net margins mean scale alone has not produced operating leverage; persistent low gross profitability undermines durable earnings power even if revenue growth continues.
Negative Operating And Free Cash FlowConsistent negative operating and free cash flow indicates ongoing cash burn and reliance on external funding. Even with some improvement versus prior years, sustained negative cash generation pressures liquidity, constrains reinvestment, and raises the risk of dilution or restrictive financing that can impair long-term strategic options.
Persistent Operating Losses And Negative ReturnsOngoing operating losses and a slightly negative ROE reflect continued value erosion and signal the company has not achieved profitable scale. Persistent losses erode equity cushions over time and increase the probability of restructuring, asset sales, or equity raises if profitability trends do not reverse.
Cosmos Holdings News
COSM FAQ
What was Cosmos Holdings Inc’s price range in the past 12 months?
Cosmos Holdings Inc lowest stock price was $0.16 and its highest was $1.32 in the past 12 months.
What is Cosmos Holdings Inc’s market cap?
Cosmos Holdings Inc’s market cap is $18.17M.
When is Cosmos Holdings Inc’s upcoming earnings report date?
Cosmos Holdings Inc’s upcoming earnings report date is Aug 24, 2026 which is in 42 days.
How were Cosmos Holdings Inc’s earnings last quarter?
Currently, no data Available
Is Cosmos Holdings Inc overvalued?
According to Wall Street analysts Cosmos Holdings Inc’s price is currently Overvalued.
Does Cosmos Holdings Inc pay dividends?
Cosmos Holdings Inc does not currently pay dividends.
What is Cosmos Holdings Inc’s EPS estimate?
Cosmos Holdings Inc’s EPS estimate is 0.01.
How many shares outstanding does Cosmos Holdings Inc have?
Cosmos Holdings Inc has 62,078,396 shares outstanding.
What happened to Cosmos Holdings Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cosmos Holdings Inc?
Currently, no hedge funds are holding shares in COSM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cosmos Holdings Inc
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Technical Analysis
Ownership Overview
25.46% Insiders
0.49% Mutual Funds
<0.01% Other Institutional Investors
73.77% Public Companies and
Individual Investors